120 related articles for article (PubMed ID: 8562864)
1. Lipoprotein (a) and fibrinolytic system in liver cirrhosis. Coagulation Abnormalities in Liver Cirrhosis (CALC) Study Group.
Cimminiello C; Soncini M; Gerosa MC; Toschi V; Motta A; Bonfardeci G
Biomed Pharmacother; 1995; 49(7-8):364-8. PubMed ID: 8562864
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic parameters, lipid status and lipoprotein(a) in ischemic stroke patients.
Vucković BA; Djerić MJ; Ilić TA; Canak VB; Kojić-Damjanov SLj; Zarkov MG; Cabarkapa VS
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():12-7. PubMed ID: 20229676
[TBL] [Abstract][Full Text] [Related]
3. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
[TBL] [Abstract][Full Text] [Related]
4. Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease.
Suefuji H; Ogawa H; Yasue H; Imoto N; Sakamoto T; Miyao Y; Kaikita K; Soejima H; Nishiyama K
Coron Artery Dis; 1996 Feb; 7(2):167-72. PubMed ID: 8813450
[TBL] [Abstract][Full Text] [Related]
5. Does Lp(a) lipoprotein inhibit the fibrinolytic system?
Halvorsen S; Skjønsberg OH; Berg K; Ruyter R; Godal HC
Thromb Res; 1992 Nov; 68(3):223-32. PubMed ID: 1471070
[TBL] [Abstract][Full Text] [Related]
6. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
Matsuura R; Soma M; Maeda Y; Kasakura S
Rinsho Byori; 1995 Dec; 43(12):1256-60. PubMed ID: 8569037
[TBL] [Abstract][Full Text] [Related]
8. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipoprotein(a) levels and fibrinolytic activity in patients with unstable angina.
Okubo H; Yasue H; Ogawa H; Misumi I; Masuda T; Miyao Y; Sakamoto T
Jpn Circ J; 1993 Oct; 57(10):947-54. PubMed ID: 7901435
[TBL] [Abstract][Full Text] [Related]
10. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
[TBL] [Abstract][Full Text] [Related]
11. ; PARAMETERS OF FIBRINOLYTIC AND ANTIFIBRINOLYTIC ACTIVITY IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS ASSOCIATED WITH ADIPOSITY.
Virstiuk N; Matkovska N
Georgian Med News; 2020; (304-305):37-43. PubMed ID: 32965247
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting fibrinolytic potential: cardiovascular fitness, body composition, and lipoprotein(a).
Szymanski LM; Durstine JL; Davis PG; Dowda M; Pate RR
Metabolism; 1996 Nov; 45(11):1427-33. PubMed ID: 8931650
[TBL] [Abstract][Full Text] [Related]
13. The effects of green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom on the fibrinolytic system in human.
Rojnuckarin P; Intragumtornchai T; Sattapiboon R; Muanpasitporn C; Pakmanee N; Khow O; Swasdikul D
Toxicon; 1999 May; 37(5):743-55. PubMed ID: 10219986
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndrome.
Hong SY; Yang DH
Nephron; 1995; 69(2):125-30. PubMed ID: 7723892
[TBL] [Abstract][Full Text] [Related]
16. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic parameters and lipoprotein(a) in young women with myocardial infarction.
Salobir B; Sabovic M; Peternel P; Stegnar M
Angiology; 2002; 53(2):157-63. PubMed ID: 11952105
[TBL] [Abstract][Full Text] [Related]
18. Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a).
Aznar J; Estellés A; Bretó M; España F; Alós T
Thromb Res; 1992 Jun; 66(5):569-82. PubMed ID: 1387993
[TBL] [Abstract][Full Text] [Related]
19. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
[TBL] [Abstract][Full Text] [Related]
20. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.
Huber K; Kirchheimer JC; Korninger C; Binder BR
Thromb Res; 1991 Jun; 62(5):491-500. PubMed ID: 1910213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
